Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Neoplasms, Cystic, Mucinous, and Serous 2Thyroid Nodule 1Sexual Behavior 1Pancreatic Neoplasms 1Pancreatic Mucinous-Cystic Neoplasm 1Pancreatic Cyst 1Neuroblastoma 1Multiple Endocrine Neoplasia Type 1 1Mucinous Cystic Tumor With Moderate Dysplasia 1Homosexuality 1Alcohol Drinking 1

Interventions

Docetaxel 43enzalutamide 31Prednisone 25Abiraterone Acetate 24Magnetic Resonance Spectroscopy 18abiraterone 15pembrolizumab 14bicalutamide 14Radiotherapy 14Cyclophosphamide 13darolutamide 12Leuprolide 12Goserelin 12apalutamide 10Ipilimumab 10olaparib 9Specimen Handling 9Radiosurgery 9Radiation 9Injections 9Biopsy 9Pluvicto 8Paclitaxel 8Radiotherapy, Intensity-Modulated 7Carboplatin 7sargramostim 6fludarabine 6cabazitaxel 6Sirolimus 6Nivolumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Prostatic Neoplasms × Ethanol × Clear all
NCT07100847 2025-09-09

Periprostatic Neurolysis in Prostate Cancer

University of Texas Southwestern Medical Center

Phase 1 Recruiting
21 enrolled
Genitourinary

Prostatic Neoplasms

NCT06703437 2025-09-03

Long Acting Neuraxial Peri-prostatic Block in Cancer

Icahn School of Medicine at Mount Sinai

Phase 1 Active not recruiting
12 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡